University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Stribild

Stribild (Elvitegravir + Cobicistat + Viread + Emtriva)

Type of Drug: Fixed-Dose Combination

Fixed-dose combinations combine the most commonly prescribed doses of more than 1 medication into a single pill.

Approved adult dosing

Vitekta 150 mg + Tybost 150 mg + Viread 300 mg + Emtriva 200 mg in a single tablet

  • image of a Stribild pill

    one tablet

Notes on taking this medication

  • Take with a full meal (do not take without food)
  • Stribild can interact with many other drugs; persons using Stribild with those drugs may need an adjustment to their dose of the other drugs; consult your medical provider
  • Persons with kidney problems may need an adjustment to their doses of the component drugs, so may not be able to take this combination pill

Side effects

    Stribild has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug

See accompanying chart: Tips for Common Side Effects

Same side effects as

Vitekta

  • Diarrhea, headache

Tybost

  • Nausea, diarrhea
  • Headache
  • Fatigue
  • Elevation in blood creatinine levels (this is used to assess kidney function; your provider will monitor creatinine)

Viread

  • Gassiness; abdominal discomfort; nausea; diarrhea
  • Kidney impairment
  • Bone impairment
  • Viread is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

Emtriva

  • Skin discoloration (particularly in dark-skinned people)
  • Headache; diarrhea; nausea
  • Emtriva is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Contents
Scroll over drug name to see other names for the drug.